artesunic acid has been researched along with Sjogren's Syndrome in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 2 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Han, M; Huang, E; Jiang, Q; Lu, L; Rui, K; Tian, J; Wu, Y; Xiao, F; Zhang, L; Zou, L | 1 |
| Fu, J; Shao, Y; Shi, H; Wang, B; Ye, L; Zhan, T; Zheng, L | 1 |
2 other study(ies) available for artesunic acid and Sjogren's Syndrome
| Article | Year |
|---|---|
Artesunate suppresses Th17 response via inhibiting IRF4-mediated glycolysis and ameliorates Sjog̈ren's syndrome.
Topics: Artesunate; Glycolysis; Humans; Sjogren's Syndrome; Th17 Cells | 2022 |
Artesunate inhibits Sjögren's syndrome-like autoimmune responses and BAFF-induced B cell hyperactivation via TRAF6-mediated NF-κB signaling.
Topics: Animals; Artesunate; Autoantibodies; Autoimmunity; B-Cell Activating Factor; B-Lymphocytes; Cell Line, Tumor; Disease Models, Animal; Humans; Immunologic Factors; Intracellular Signaling Peptides and Proteins; Lymphocytes; Mice, Inbred ICR; Mice, Inbred NOD; NF-kappa B; Salivary Glands; Signal Transduction; Sjogren's Syndrome | 2021 |